Aramark director granted 84.69 stock-equivalent rights

Aramark director Patricia E. Lopez reported an acquisition of 84.690 shares of common stock-equivalent rights on March 4, 2026.

Rhea-AI Filing Summary

Aramark director Patricia E. Lopez reported an acquisition of 84.690 shares of common stock-equivalent rights on March 4, 2026. These are dividend equivalent rights credited on deferred stock units in connection with Aramark’s quarterly dividend and carry a price of $0.0000 per share.

After this grant/award acquisition, Lopez’s directly held common stock and related rights total 29,077.206 shares. The dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards, aligning the additional units with her existing equity compensation timeline.

Insider Trade Summary

Grant/Award: 84.69 shares

Grant/Award 1 txn

Insider LOPEZ PATRICIA E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	84.69	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,077.206 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Patricia E. Lopez?

Aramark reported that director Patricia E. Lopez acquired 84.690 dividend equivalent rights tied to common stock on March 4, 2026. These rights were credited on deferred stock units in connection with the company’s quarterly dividend and carry a price of $0.0000 per unit.

How many Aramark (ARMK) shares does Patricia E. Lopez hold after this Form 4?

Following the March 4, 2026 grant, Patricia E. Lopez is reported as directly holding a total of 29,077.206 shares of Aramark common stock and related rights. This figure includes the newly credited 84.690 dividend equivalent rights on her deferred stock units.

What are the 84.690 dividend equivalent rights reported by Aramark (ARMK)?

The 84.690 units are dividend equivalent rights credited on deferred stock units held by Patricia E. Lopez. They mirror dividends paid on Aramark’s common stock and are issued at $0.0000 per unit, functioning as stock-based compensation linked to her existing equity awards.

How do the dividend equivalent rights for Aramark (ARMK) vest for Patricia E. Lopez?

Aramark states these dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards. This means their vesting follows the original equity grant timelines, maintaining consistent long-term incentive alignment for Patricia E. Lopez as a director.

Was the Aramark (ARMK) insider transaction a market purchase or sale?

The transaction is classified as a grant, award, or other acquisition under code A, not an open-market buy or sell. Patricia E. Lopez received 84.690 dividend equivalent rights at $0.0000 per unit, reflecting stock-based compensation rather than a cash transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOPEZ PATRICIA E

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		84.69(1)	A	$0	29,077.206	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.